Please check back on the 1st of the month to view the Immunomedics, Inc. Annual Reports. In the meantime, here are a few annual reports from similar companies.
Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe.
Search by company name or ticker symbol